Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03397654
Title Study of Pembrolizumab Following TACE in Primary Liver Carcinoma (PETAL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Imperial College London
Indications

liver carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.